A healthcare worker in blue protective gear, including a mask and face shield, is standing beside a seated patient in a hospital setting. The patient, with an arm cuff, is looking at a monitor displaying vital signs. Sunlight filters through large windows behind them.

R&D Insight: Unique views into immuno-oncology

CAR-T cell therapy and antibody-drug conjugates are two promising innovative immunotherapy approaches, but amongst all of the recent news and publications, it can be challenging to stay ahead of the emerging trends.  This idea in brief is a quick executive summary that identifies emerging trends, new opportunities, and key players in the immuno-oncology landscape.  Discover new modalities, checkpoint inhibitors, biomarkers, and targets that are growing quickly in our latest executive summary.  Download and share here:

Immuno-oncology
Download the executive summary

Related CAS Insights

Drug Discovery

ACE2:靶向疾病发病机制中的潜在重要受体

December 15, 2022

Read article
Drug Discovery

ACS 分子胶和靶向蛋白降解网络研讨会

October 12, 2022

Read article
Drug Discovery

AI 药物发现:评估首批进入人体临床试验阶段的 AI 设计候选药物

September 23, 2022

Read article

Gain new perspectives for faster progress directly to your inbox.